Sign up to get full access to all our latest press releases and newsletters.
Sign UpJuly 24th, 2024
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
May 15th, 2024
Organigram Reports Second Quarter Fiscal 2024 Results
April 8th, 2024
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
March 26th, 2024
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
February 28th, 2024
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty
February 13th, 2024
Organigram Reports First Quarter Fiscal 2024 Results
January 24th, 2024
Organigram Announces the First Tranche Closing from BAT Investment
January 19th, 2024
Organigram Announces Appointment of Karina Gehring to Board of Directors
January 19th, 2024
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT
December 29th, 2023
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
December 19th, 2023